Ben Greenfield's guest explains how insurers and drug makers inflate prices through rebate schemes, using insulin as an example, then discusses Muse cells, immune cells that shrank tumors in mice without causing cancer themselves.
Describe to me in a little bit more detail what a rebate actually is. How's a rebate work? So like insulin was a prime example. I'm not even telling you this. The Senate Finance Committee has done investigations into the big insurance companies to try and uncover why the cost of prescription drug care, like a product like insulin, even though it costs a fraction of the dollar amount to create it today, why has it gone up 10x? Yeah. And the answer is because the middleman insurance companies have negotiated kickbacks tax on every single prescription drug. So they go to the, they go to the big pharmaceutical company like Lilly and they go, hey, instead of selling it for $150, sell it to us for $300, give us $150 rebate. Other huge, huge benefit of Muse is they are non-tumorigenic. Literally, in all of the studies, they do not ever become tumors. Not only do they not become tumors, I'm not saying that they're going to heal or stop or prevent cancer, but for the sake of safety, Mari tested injecting intravenous immune cells into cancer-ridden mice, and it shrunk tumors. It immunomodulated and began to try to fix and repair the damage of these, uh, tumor cells, tumorigenic cells. Now, it's not going to heal that. It's not. But the point is, it's not going to cause a tumor, and it's not going to exacerbate
The Solution to Aging Might Be Closer Than Anyone Realizes - With Ben Goertzel
